AZ's Farxiga Fillip As Drug Reduces Renal Disease Risk In Type 2 Diabetics
Executive Summary
AstraZeneca has presented more data on Farxiga at the American Diabetes Association meeting which should help the SGLT2 inhibitor in its battles with Jardiance and Invokana.